E-LIB Suche - Ergebnisse für: Foulon, Stéphanie

1

Impact of pembrolizumab treatment duration on overall survi..:

Rousseau, Adrien ; Michiels, Stefan ; Simon-Tillaux, Noémie...
The Lancet Regional Health - Europe. 43 (2024) - p. 100970 , 2024

Link: https://doi.org/10.1016/..

2

Activity of Lutetium-177 Prostate-specific Membrane Antigen..:

Flippot, Ronan ; Telli, Tugce ; Velev, Maud...
European Urology Oncology. , 2024

Link: https://doi.org/10.1016/..

3

A Randomized, Open-label, Cross-over Phase 2 Trial of Darol..:

Colomba, Emeline ; Jonas, Sarah Flora ; Eymard, Jean-Christophe...
European Urology. 85 (2024) 3 - p. 274-282 , 2024

Link: https://doi.org/10.1016/..

4

An International Comparison of Presentation, Outcomes and C..:

Wysocki, Oskar ; Zhou, Cong ; Rogado, Jacobo...
Cancers. 14 (2022) 16 - p. 3931 , 2022

Link: https://doi.org/10.3390/..

5

Abiraterone plus prednisone added to androgen deprivation t..:

Fizazi, Karim ; Foulon, Stéphanie ; Carles, Joan...
The Lancet. 399 (2022) 10336 - p. 1695-1707 , 2022

Link: https://doi.org/10.1016/..

6

What does a non-response to induction chemotherapy imply in..:

Adelon, Jihane ; Dufour, Christelle ; Foulon, Stéphanie...
Journal of Neuro-Oncology. 153 (2021) 3 - p. 425-440 , 2021

Link: https://doi.org/10.1007/..

7

Secondary haemophagocytic lymphohistiocytosis is a rare occ..:

Hueso, Thomas ; Bouchez, Clémentine ; Salviat, Flore...
British Journal of Haematology. 192 (2020) 3 - p. , 2020

Link: https://doi.org/10.1111/..

8

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatot..:

Maillard, Maud ; Chevreau, Christine ; Le Louedec, Félicien...
Cancers. 12 (2020) 12 - p. 3647 , 2020

Link: https://doi.org/10.3390/..

9

Prognostic relevance of clinical and molecular risk factors..:

Dufour, Christelle ; Foulon, Stephanie ; Geoffray, Anne...
Neuro-Oncology. , 2020

Link: https://doi.org/10.1093/..

10

Using healthcare claims data to analyze the prevalence of B..:

Foulon, Stéphanie ; Cony‐Makhoul, Pascale ; Guerci‐Bresler, Agnès...
Cancer Medicine. 8 (2019) 6 - p. 3296-3304 , 2019

Link: https://doi.org/10.1002/..

11

Anticancer Activity and Tolerance of Treatments Received Be..:

Lavaud, Pernelle ; Gravis, Gwenaëlle ; Foulon, Stéphanie...
European Urology. 73 (2018) 5 - p. 696-703 , 2018

Link: https://doi.org/10.1016/..

12

The rising prevalence of chronic myeloid leukemia in France:

Delord, Marc ; Foulon, Stéphanie ; Cayuela, Jean-Michel..
Leukemia Research. 69 (2018) - p. 94-99 , 2018

Link: https://doi.org/10.1016/..

13

Self-controlled designs in pharmacoepidemiology involving e..:

Gault, Nathalie ; Castañeda-Sanabria, Johann ; De Rycke, Yann...
BMC Medical Research Methodology. 17 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

14

Healthcare expenditure of multiple sclerosis patients in 20..:

Lefeuvre, Delphine ; Rudant, Jérémie ; Foulon, Stéphanie..
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3 (2017) 3 - p. 205521731773042 , 2017

Link: https://doi.org/10.1177/..

15

The cost of molecular-guided therapy in oncology: a prospec..:

Pagès, Arnaud ; Foulon, Stéphanie ; Zou, Zhaomin...
Genetics in Medicine. 19 (2017) 6 - p. 683-690 , 2017

Link: https://doi.org/10.1038/..